41 related articles for article (PubMed ID: 12789260)
1. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.
Marabese M; Vikhanskaya F; Rainelli C; Sakai T; Broggini M
Nucleic Acids Res; 2003 Nov; 31(22):6624-32. PubMed ID: 14602923
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.
Cinti C; Leoncini L; Nyongo A; Ferrari F; Lazzi S; Bellan C; Vatti R; Zamparelli A; Cevenini G; Tosi GM; Claudio PP; Maraldi NM; Tosi P; Giordano A
Am J Pathol; 2000 Mar; 156(3):751-60. PubMed ID: 10702389
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.
Liontos M; Niforou K; Velimezi G; Vougas K; Evangelou K; Apostolopoulou K; Vrtel R; Damalas A; Kontovazenitis P; Kotsinas A; Zoumpourlis V; Tsangaris GT; Kittas C; Ginsberg D; Halazonetis TD; Bartek J; Gorgoulis VG
Am J Pathol; 2009 Jul; 175(1):376-91. PubMed ID: 19541929
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.
Fogal V; Hsieh JK; Royer C; Zhong S; Lu X
EMBO J; 2005 Aug; 24(15):2768-82. PubMed ID: 16037820
[TBL] [Abstract][Full Text] [Related]
5. The E2F4/p130 Repressor Complex Cooperates with Oncogenic ΔNp73α To Inhibit Gene Expression in Human Papillomavirus 38 E6/E7-Transformed Keratinocytes and in Cancer Cells.
Taverniti V; Krynska H; Venuti A; Straub ML; Sirand C; Lohmann E; Romero-Medina MC; Moro S; Robitaille A; Negroni L; Martinez-Zapien D; Masson M; Tommasino M; Zanier K
mSphere; 2023 Apr; 8(2):e0005623. PubMed ID: 36883841
[TBL] [Abstract][Full Text] [Related]
6. Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors.
Masciullo V; Valdivieso P; Amadio G; Santoro A; Angelico G; Sgambato A; Boffo S; Giordano A; Scambia G; Zannoni GF
Front Med (Lausanne); 2020; 7():596226. PubMed ID: 33262995
[TBL] [Abstract][Full Text] [Related]
7. Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells.
Tornín J; Gallego B; Rey V; Murillo D; Huergo C; Rodríguez A; Canal C; Rodríguez R
Free Radic Biol Med; 2023 Nov; 209(Pt 1):127-134. PubMed ID: 37844652
[TBL] [Abstract][Full Text] [Related]
8. Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts.
Watanabe T; Sullenger BA
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8490-4. PubMed ID: 10890910
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Continuum of Molecular Assemblies for Controlling Cell Fates.
Wang H; Feng Z; Xu B
Chembiochem; 2019 Oct; 20(19):2442-2446. PubMed ID: 30957316
[TBL] [Abstract][Full Text] [Related]
10. RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines.
Pentimalli F; Forte IM; Esposito L; Indovina P; Iannuzzi CA; Alfano L; Costa C; Barone D; Rocco G; Giordano A
Oncogene; 2018 Jul; 37(27):3657-3671. PubMed ID: 29606701
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of PARP1 transcription by promoter-associated E2F4-RBL2-HDAC1-BRM complex contributes to repression of pluripotency stem cell factors in human monocytes.
Wiśnik E; Płoszaj T; Robaszkiewicz A
Sci Rep; 2017 Aug; 7(1):9483. PubMed ID: 28842672
[TBL] [Abstract][Full Text] [Related]
12. To live or let die - complexity within the E2F1 pathway.
Poppy Roworth A; Ghari F; La Thangue NB
Mol Cell Oncol; 2015; 2(1):e970480. PubMed ID: 27308406
[TBL] [Abstract][Full Text] [Related]
13. RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.
Indovina P; Pentimalli F; Casini N; Vocca I; Giordano A
Oncotarget; 2015 Jul; 6(20):17873-90. PubMed ID: 26160835
[TBL] [Abstract][Full Text] [Related]
14. Pathway landscapes and epigenetic regulation in breast cancer and melanoma cell lines.
El Baroudi M; La Sala D; Cinti C; Capobianco E
Theor Biol Med Model; 2014 May; 11 Suppl 1(Suppl 1):S8. PubMed ID: 25077705
[TBL] [Abstract][Full Text] [Related]
15. Separate and combined effects of DNMT and HDAC inhibitors in treating human multi-drug resistant osteosarcoma HosDXR150 cell line.
Capobianco E; Mora A; La Sala D; Roberti A; Zaki N; Badidi E; Taranta M; Cinti C
PLoS One; 2014; 9(4):e95596. PubMed ID: 24756038
[TBL] [Abstract][Full Text] [Related]
16. Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes.
La Sala D; Macaluso M; Trimarchi C; Giordano A; Cinti C
Oncogene; 2003 Jun; 22(23):3518-29. PubMed ID: 12789260
[TBL] [Abstract][Full Text] [Related]
17. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation.
Vairo G; Soos TJ; Upton TM; Zalvide J; DeCaprio JA; Ewen ME; Koff A; Adams JM
Mol Cell Biol; 2000 Jul; 20(13):4745-53. PubMed ID: 10848600
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
